OpenBots is an RPA platform with zero-bot licensing. The company aims to democratize robotic process automation by making RPA more accessible and enabling businesses to scale their programs. Yesterday, it was announced the company acquires araZach LLC, a healthcare, life sciences, and Salesforce solutions provider. The acquisition is meant to enhance OpenBot’s capabilities to accelerate the zero-bot license revolution within these ecosystems.
araZach started as a Salesforce consultancy with expertise in healthcare and life sciences. The araZach team has been solving “interoperability” problems within the healthcare industry using the OpenBots RPA platform extensively to build up its botConnector solution. The OpenBots platform unlocks high-impact clinical, operational data and insights from EHRs/EMRs, while seamlessly integrating into Salesforce and other applications.
“Healthcare companies need their data to be interoperable throughout all their systems, across the continuum of care. With the full power of the OpenBots world-class automation platform behind us, we have a tremendous opportunity to realize our vision of democratizing and scaling the adoption of RPA. Together, OpenBots and araZach will accelerate our customers’ transformations into the age of automation, enabling them to grow their RPA programs more profitably.”
Shahzad Khokar (pictured), Founder and Chief Advisor, araZach
“The healthcare industry has always been a prime candidate for automation. OpenBots helps customers to overcome their challenges with EHR and legacy systems using our platform. We think it is time to offer that to the entire industry. We built the OpenBots platform keeping in mind the specific requirements of the healthcare industry, including privacy, confidentiality, and security requirements.”
Ashish Nangla, Co-founder and CTO, OpenBots
